112
IRulya Therapeutics Inc. (QNCX)
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
93.7
FY23:
77.4
FY24:
44.0
FY25:
22.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
21.6
FY22:
10.2
FY23:
90.5
FY24:
70.4
FY25:
70.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
133
FY22:
104
FY23:
168
FY24:
114
FY25:
93.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.2
FY22:
3.07
FY23:
9.57
FY24:
7.28
FY25:
43.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.42
FY22:
0.25
FY23:
73.2
FY24:
77.1
FY25:
86.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
101
FY23:
85.1
FY24:
30.1
FY25:
−35.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
133
FY22:
104
FY23:
168
FY24:
114
FY25:
93.5
All amounts in millions USD